New paper
Recovery to Intended Oncologic Therapy After Upfront Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
How do patient-reported and observed measures of shared decision-making compare in pancreatic cancer care? Insights from a cross-sectional study.
Why it was picked newest record on or before this date
New paper
Erianin targets glutathione reductase to trigger immunogenic cell death and sensitize pancreatic cancer to PD-1 blockade.
Why it was picked newest record on or before this date
New paper
IL-37 links ACLY-centered lipid metabolic reprogramming to myeloid immunosuppression in pancreatic ductal adenocarcinoma.
Why it was picked newest record on or before this date
New paper
Mutational signature landscape of pancreatic cancer genomes from nine countries
Why it was picked newest record on or before this date
Also today
New paper
Redox Damage Tolerance Thresholds in KRAS-Driven Pancreatic Cancer Initiation
New paper
Tumour Regression Grade as a Predictor of Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Limitations of a Post-Surgical Indicator of Prognosis.
New paper
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial
New paper
3D tissue model to patient atlas: dynamic network topology reveals PDAC chemoresistance bottlenecks.
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.